+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
ID06967857

Randomized, Double-Blind Trial Comparing Two Dexamfetamine Sulfate Formulations Versus Placebo in Adults With ADHD and Moderate to Severe Depression

Led by Prof. Dr. Frank Behrens · Updated on 2026-09-25

105

Participants Needed

5

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Adults with attention-deficithyperactivity disorder ADHD often have other psychiatric disorders, with depression being particularly common, affecting up to half of these individuals. Researchers are studying two different formulations of dexamfetamine sulfate to assess their safety and effectiveness compared to placebo in adults who have ADHD alongside moderate to severe depression. This clinical trial is designed as a randomized, double-blind study to provide clear evidence about these treatments in this population. Participants will receive one of three treatments dexamfetamine immediate-release tablets taken twice daily, dexamfetamine extended-release capsules taken once daily, or a placebo in the form of tablets or capsules to maintain blinding. The study will last approximately 16 weeks of treatment, with various visits scheduled to monitor effects and collect data. Placebo will be administered in forms matching the active drugs to ensure the study remains blinded. During the trial, participants will undergo regular assessments including monitoring for adverse events, clinical global impression ratings, and depression rating scales such as the Montgomery-sberg Depression Rating Scale MADRS. Researchers will also track medication doses and adherence. The main outcome is the incidence of adverse events until the end of study at week 17, with multiple secondary outcomes evaluating safety and clinical efficacy. Participants will be followed closely throughout the study period to ensure safety and collect comprehensive data.

CONDITIONS

Brief Title

Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression

Research Team

C

Christin Jonetzko

A

Anja Kuehne

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here